LAVA Therapeutics NV

NASDAQ:LVTX  
12.00
-0.24 (-1.96%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

LAVA Therapeutics NV Stock, NASDAQ:LVTX

Yalelaan 60, Utrecht, Noord-Brabant 3584 CM
Netherlands
Phone: +31.63.000.30.35
Number of Employees: 31

Description

LAVA Therapeutics NV operates as a biotechnology company, which develops immune oncology biopharmaceutical products. The firm develops next generation T-cell engaging bispecific antibodies to treat cancer. The company was founded by Erik van den Berg in 2016 and is headquartered in Utrecht, the Netherlands.